A report commissioned by the European pharmaceutical industry federation, EFPIA, has pointed to significant gaps in understanding the broader public health impact of various clinical trial data disclosure activities.
Despite increasing volumes of data being made public in response to the ever evolving mandatory and voluntary clinical trial disclosure...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?